ATE239495T1 - Verbesserung der follikelgenese - Google Patents

Verbesserung der follikelgenese

Info

Publication number
ATE239495T1
ATE239495T1 AT99961017T AT99961017T ATE239495T1 AT E239495 T1 ATE239495 T1 AT E239495T1 AT 99961017 T AT99961017 T AT 99961017T AT 99961017 T AT99961017 T AT 99961017T AT E239495 T1 ATE239495 T1 AT E239495T1
Authority
AT
Austria
Prior art keywords
folliclegenesis
improve
gdf
gonadotropins
maturation
Prior art date
Application number
AT99961017T
Other languages
English (en)
Inventor
Duin Marcel Van
Ursula Maria Rose
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE239495T1 publication Critical patent/ATE239495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/19—Growth and differentiation factors [GDF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
AT99961017T 1998-12-01 1999-11-25 Verbesserung der follikelgenese ATE239495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204048 1998-12-01
PCT/EP1999/009210 WO2000032222A1 (en) 1998-12-01 1999-11-25 Improvement of folliculogenesis

Publications (1)

Publication Number Publication Date
ATE239495T1 true ATE239495T1 (de) 2003-05-15

Family

ID=8234412

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99961017T ATE239495T1 (de) 1998-12-01 1999-11-25 Verbesserung der follikelgenese

Country Status (11)

Country Link
US (1) US6660717B1 (de)
EP (1) EP1135154B1 (de)
JP (1) JP2002531414A (de)
AT (1) ATE239495T1 (de)
AU (1) AU770933B2 (de)
CA (1) CA2353085A1 (de)
DE (1) DE69907725T2 (de)
DK (1) DK1135154T3 (de)
ES (1) ES2200579T3 (de)
PT (1) PT1135154E (de)
WO (1) WO2000032222A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1176976E (pt) * 1999-05-07 2006-11-30 Applied Research Systems Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
KR101502110B1 (ko) * 2005-07-18 2015-03-12 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 과립층 세포의 세포자멸사 조절
AU2012351977B2 (en) 2011-12-14 2018-03-22 The Board Of Trustees Of The Leland Stanford Junior University Stimulation of ovarian follicle development and oocyte maturation
CN112010271B (zh) * 2020-09-28 2022-03-25 江南大学 一种球形硒纳米颗粒及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
JP3482207B2 (ja) * 1993-01-12 2003-12-22 ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子−９
US5821056A (en) * 1993-01-12 1998-10-13 The Johns Hopkins University School Of Medicine Growth differentiation factor-9
JPH09508114A (ja) 1994-01-20 1997-08-19 アクゾ・ノベル・エヌ・ベー 卵胞刺激活性を有する糖タンパク質イソ型新規組成物
WO1997031020A1 (en) 1996-02-22 1997-08-28 The General Hospital Corporation METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS
DE69814352T3 (de) * 1997-02-07 2009-08-13 Stryker Corp., Kalamazoo Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung

Also Published As

Publication number Publication date
CA2353085A1 (en) 2000-06-08
JP2002531414A (ja) 2002-09-24
EP1135154A1 (de) 2001-09-26
DK1135154T3 (da) 2003-08-11
WO2000032222A1 (en) 2000-06-08
ES2200579T3 (es) 2004-03-01
US6660717B1 (en) 2003-12-09
DE69907725D1 (de) 2003-06-12
PT1135154E (pt) 2003-08-29
AU1777800A (en) 2000-06-19
DE69907725T2 (de) 2004-03-18
EP1135154B1 (de) 2003-05-07
AU770933B2 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
GT199800197AA (es) Proceso para la sintesis de 1,3-dioles
YU28503A (sh) Humanizovana anti-lt-beta-r antitela
DK0741694T3 (da) Phenyleddikesyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling og midler indeholdende disse
ID26992A (id) Kantong berisi pengharum yang lepas lama metode penggunaannya dan metode pembuatannya
EE200200337A (et) Uued ühendid ning nende kasutamine
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
ATE239495T1 (de) Verbesserung der follikelgenese
NO970473D0 (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
ID18154A (id) Amplop dapat digunakan kembali yang mudah dibuka
DE69533311D1 (de) Verfahren zur behandlung von autoimmunerkrankungen mittels typ-1-interferonen
NO974708L (no) Levobupivacain og dets anvendelse som anestetikum i gravide kvinner
AU736977C (en) Peptide-based immunotherapeutic agent
DE69429664D1 (de) Verwendung von relaxin als schmerzstiller und -dämpfer für starken schmerz
AU5615594A (en) Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods
FI942422L (fi) Menetelmä fysostigmiinin valmistuksessa käytettyjen välituotteiden enantioselektiivistä synteesiä varten
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum
DE69721831D1 (de) Aphrodisiakum zur anwendung an den geschlechtsorganen
DE60028750D1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
FI951055A7 (fi) Menetelmä androstenonipitoisuuksien määrittämiseksi rasvakudoksissa
DK0800819T3 (da) Kropsplejemiddel og fremgangsmåde til dets fremstilling
HN1998000013A (es) Metodo para la preparacion de (is,4q)-1-azabiciclo (2.2.1) heptano 3-uno y (1r,45), 1-azabiciclo (2.2.1) heptano 3-uno.
ES2099613T3 (es) Empleo de hidroxinaftalinas en agentes colorantes.
BR9508432A (pt) Processo para a preparação de 2,5-dimetil-2,5-dihidroperóxi-hexano
NO20004242L (no) Substituert 1,2,4-triazolo[3,4-a]pyridazin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1135154

Country of ref document: EP

REN Ceased due to non-payment of the annual fee